We found again that the tumor growth delay and survival benefit (Supplementary Fig. 7b, c) of small targeted LAIR-IL2 was indistinguishable from large untargeted LAIRx-LAIRx-MSAH464Q-IL2. The gene discussed is IL2; the disease is neoplasm.